Equifax Other Non-Current Liabilities increased by 3.1% to $248.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.3%, from $238.30M to $248.50M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 6.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $184.90M | $185.00M | $190.00M | $188.80M | $176.80M | $170.80M | $178.60M | $172.10M | $176.50M | $215.60M | $250.70M | $268.20M | $266.70M | $264.50M | $247.20M | $238.30M | $241.30M | $237.90M | $241.10M | $248.50M |
| QoQ Change | — | +0.1% | +2.7% | -0.6% | -6.4% | -3.4% | +4.6% | -3.6% | +2.6% | +22.2% | +16.3% | +7.0% | -0.6% | -0.8% | -6.5% | -3.6% | +1.3% | -1.4% | +1.3% | +3.1% |
| YoY Change | — | — | — | — | -4.4% | -7.7% | -6.0% | -8.8% | -0.2% | +26.2% | +40.4% | +55.8% | +51.1% | +22.7% | -1.4% | -11.1% | -9.5% | -10.1% | -2.5% | +4.3% |